ARCA biopharma, Inc. (ABIO) earnings
Quarterly and annual ABIO reports and results, each read against the price at its own news timestamp. Back to the ABIO overview →
5 measured ABIO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | -1.16% | +3.32% | |
| Form 10-Q ARCA biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.16% | +3.32% | |
| ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update | Press release | -2.99% | -2.72% | |
| Form 10-Q ARCA biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.99% | -2.72% | |
| Form 10-K ARCA biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.19% |
Keep exploring
More ABIO: analyst actions → · SEC filings → · ABIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sienna Senior Living Inc (SIA_TSE) | 101 | +0.25% | 65% |
| Mynd.ai, Inc. American Depositary Shares (MYND) | 100 | +0.52% | 58% |
| Axonics, Inc. (AXNX) | 99 | +0.01% | 51% |
| Novo Integrated Sciences, Inc. (NVOS) | 99 | 0.00% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.